IBO Impact BioMedical Total Debt to Capital

Impact BioMedical Inc (IBO) is a diversified biotech holding company whose strategy relies on a broad spectrum of developments, creating risks due to resource dilution. This chart on GURU.Markets tracks the asset value at 0.00, while a lack of sales leaves the company dependent on patent valuations. Geopolitical tensions further complicate the situation, hindering drug exports and disrupting raw material supplies.

The total debt-to-equity ratio measures the degree of financial leverage by comparing total liabilities to equity to assess a business's dependence on external borrowing. Amidst an R&D lull, the current leverage ratio of Impact BioMedical Inc (IBO) reflects the resilience of its balance sheet structure in the absence of active operational cash flow, determining the extent to which assets are protected from credit risks.